Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Torpedo californica | Vesicular acetylcholine transporter | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K08155 MFS transporter, DHA1 family, solute carrier family 18 (vesicular, putative | Get druggable targets OG5_133283 | All targets in OG5_133283 |
Echinococcus granulosus | vesicular acetylcholine transporter | Get druggable targets OG5_133283 | All targets in OG5_133283 |
Echinococcus multilocularis | vesicular acetylcholine transporter | Get druggable targets OG5_133283 | All targets in OG5_133283 |
Onchocerca volvulus | Vesicular acetylcholine transporter homolog | Get druggable targets OG5_133283 | All targets in OG5_133283 |
Schistosoma mansoni | vesicular acetylcholine transporter | Get druggable targets OG5_133283 | All targets in OG5_133283 |
Brugia malayi | vesicular acetylcholine transporter unc-17 | Get druggable targets OG5_133283 | All targets in OG5_133283 |
Loa Loa (eye worm) | vesicular acetylcholine transporter unc-17 | Get druggable targets OG5_133283 | All targets in OG5_133283 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | abnormal catecholamine distribution protein 1 | Vesicular acetylcholine transporter | 515 aa | 427 aa | 38.6 % |
Brugia malayi | Abnormal catecholamine distribution protein 1 | Vesicular acetylcholine transporter | 515 aa | 431 aa | 37.6 % |
Onchocerca volvulus | Vesicular acetylcholine transporter | 515 aa | 456 aa | 53.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | conserved hypothetical protein | 0.0025 | 0 | 0.5 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.0088 | 0.2391 | 0.2188 |
Plasmodium falciparum | holo-[acyl-carrier-protein] synthase, putative | 0.0025 | 0 | 0.5 |
Schistosoma mansoni | vesicular acetylcholine transporter | 0.0267 | 0.9184 | 0.9163 |
Schistosoma mansoni | glutaminase | 0.0289 | 1 | 1 |
Mycobacterium ulcerans | glutaminase | 0.0289 | 1 | 1 |
Onchocerca volvulus | 0.025 | 0.854 | 0.9278 | |
Plasmodium vivax | SET domain protein, putative | 0.0032 | 0.0259 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.025 | 0.8524 | 0.926 |
Brugia malayi | vesicular acetylcholine transporter unc-17 | 0.0267 | 0.9184 | 0.9163 |
Entamoeba histolytica | hypothetical protein | 0.0025 | 0 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0064 | 0.1494 | 0.1268 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0064 | 0.1494 | 0.1383 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0064 | 0.1494 | 1 |
Onchocerca volvulus | Vesicular acetylcholine transporter homolog | 0.0267 | 0.9184 | 1 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0032 | 0.0259 | 0.1732 |
Treponema pallidum | 4'-phosphopantetheinyl transferase | 0.0025 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.025 | 0.8524 | 0.8485 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.025 | 0.8524 | 0.9264 |
Schistosoma mansoni | survival motor neuron protein | 0.0051 | 0.0994 | 0.0755 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.0088 | 0.2391 | 0.2388 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0064 | 0.1494 | 1 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0064 | 0.1494 | 1 |
Onchocerca volvulus | 0.0088 | 0.2391 | 0.2388 | |
Schistosoma mansoni | hypothetical protein | 0.0051 | 0.0994 | 0.0755 |
Echinococcus multilocularis | vesicular acetylcholine transporter | 0.0267 | 0.9184 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0064 | 0.1494 | 0.1426 |
Loa Loa (eye worm) | hypothetical protein | 0.0088 | 0.2391 | 0.2188 |
Wolbachia endosymbiont of Brugia malayi | 4'-phosphopantetheinyl transferase | 0.0025 | 0 | 0.5 |
Echinococcus granulosus | vesicular acetylcholine transporter | 0.0267 | 0.9184 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0064 | 0.1494 | 0.1494 |
Onchocerca volvulus | 0.0051 | 0.0994 | 0.0824 | |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0032 | 0.0259 | 0.0049 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0051 | 0.0994 | 0.0755 |
Schistosoma mansoni | hypothetical protein | 0.0179 | 0.5843 | 0.5733 |
Trichomonas vaginalis | glutaminase, putative | 0.0289 | 1 | 1 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.0088 | 0.2391 | 0.2426 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0064 | 0.1494 | 0.1494 |
Brugia malayi | glutaminase DH11.1 | 0.0289 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0179 | 0.5843 | 0.5733 |
Echinococcus granulosus | geminin | 0.0179 | 0.5843 | 0.6275 |
Loa Loa (eye worm) | glutaminase | 0.0289 | 1 | 1 |
Chlamydia trachomatis | holo [acyl-carrier protein] synthase | 0.0025 | 0 | 0.5 |
Echinococcus multilocularis | geminin | 0.0179 | 0.5843 | 0.6257 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0064 | 0.1494 | 0.1268 |
Loa Loa (eye worm) | vesicular acetylcholine transporter unc-17 | 0.0267 | 0.9184 | 0.9163 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0064 | 0.1494 | 0.1494 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.0088 | 0.2391 | 0.2188 |
Brugia malayi | hypothetical protein | 0.025 | 0.8524 | 0.8485 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0025 | 0 | 0.5 |
Brugia malayi | Pre-SET motif family protein | 0.022 | 0.739 | 0.7321 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.022 | 0.739 | 0.7321 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 30 nM | Inhibition of [3H]- vesamicol binding to synaptic vesicles preparation from the electric organ of T. californica | ChEMBL. | 8478910 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.